Cite

HARVARD Citation

    Vergote, I. et al. (2018). Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials. Lancet oncology. 19 (12), pp. 1680-1687. [Online]. 
  
Back to record